| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1103747960 |
| P356 | DOI | 10.1186/S12889-018-5484-8 |
| P932 | PMC publication ID | 5930778 |
| P698 | PubMed publication ID | 29716568 |
| P50 | author | Ji-Eun Park | Q57888836 |
| P2093 | author name string | Ji-Eun Park | |
| Soyoung Jung | |||
| Aeran Kim | |||
| P2860 | cites work | Outbreaks of Middle East Respiratory Syndrome in Two Hospitals Initiated by a Single Patient in Daejeon, South Korea | Q27302650 |
| Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility | Q28660530 | ||
| Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia | Q29618053 | ||
| Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea, 2015. | Q30202400 | ||
| Synthesizing data and models for the spread of MERS-CoV, 2013: key role of index cases and hospital transmission | Q30205741 | ||
| Super-spreaders in infectious diseases | Q30226492 | ||
| Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. | Q30351904 | ||
| Middle East respiratory syndrome coronavirus in Al-Madinah City, Saudi Arabia: Demographic, clinical and survival data | Q31108162 | ||
| Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study | Q33409373 | ||
| Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia | Q33431629 | ||
| Clinical Presentation and Outcomes of Middle East Respiratory Syndrome in the Republic of Korea | Q33434003 | ||
| Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients | Q33434536 | ||
| Hospital Outbreaks of Middle East Respiratory Syndrome, Daejeon, South Korea, 2015 | Q33724530 | ||
| Predictors of MERS-CoV infection: A large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia | Q40491246 | ||
| Fatality risks for nosocomial outbreaks of Middle East respiratory syndrome coronavirus in the Middle East and South Korea | Q40528960 | ||
| Association between Australian Hajj Pilgrims' awareness of MERS-CoV, and their compliance with preventive measures and exposure to camels. | Q40608264 | ||
| Middle East respiratory syndrome-related knowledge, preventive behaviours and risk perception among nursing students during outbreak | Q40641542 | ||
| Probable transmission chains of Middle East respiratory syndrome coronavirus and the multiple generations of secondary infection in South Korea | Q40689328 | ||
| Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. | Q40777987 | ||
| Acute Middle East Respiratory Syndrome Coronavirus: Temporal Lung Changes Observed on the Chest Radiographs of 55 Patients | Q40808656 | ||
| Estimating the risk of Middle East respiratory syndrome (MERS) death during the course of the outbreak in the Republic of Korea, 2015. | Q41051124 | ||
| 2014 MERS-CoV outbreak in Jeddah--a link to health care facilities | Q41351922 | ||
| High reproduction number of Middle East respiratory syndrome coronavirus in nosocomial outbreaks: Mathematical modelling in Saudi Arabia and South Korea. | Q41928429 | ||
| Transmission of MERS-coronavirus in household contacts | Q42197387 | ||
| Taking stock of the first 133 MERS coronavirus cases globally--Is the epidemic changing? | Q42245526 | ||
| A pandemic risk assessment of middle east respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia | Q43167989 | ||
| Nosocomial amplification of MERS-coronavirus in South Korea, 2015. | Q47740500 | ||
| Estimation of basic reproduction number of the Middle East respiratory syndrome coronavirus (MERS-CoV) during the outbreak in South Korea, 2015 | Q33796401 | ||
| Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study | Q35763702 | ||
| Modeling the Transmission of Middle East Respirator Syndrome Corona Virus in the Republic of Korea | Q35874539 | ||
| 2015 MERS outbreak in Korea: hospital-to-hospital transmission. | Q35942360 | ||
| Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015 | Q35951658 | ||
| Clinical determinants of the severity of Middle East respiratory syndrome (MERS): a systematic review and meta-analysis | Q36207135 | ||
| Association of Higher MERS-CoV Virus Load with Severe Disease and Death, Saudi Arabia, 2014. | Q36212118 | ||
| Mortality Risk Factors for Middle East Respiratory Syndrome Outbreak, South Korea, 2015. | Q36212164 | ||
| Middle East Respiratory Syndrome and Medical Students: Letter from China | Q36227885 | ||
| Variations in Spike Glycoprotein Gene of MERS-CoV, South Korea, 2015 | Q36418155 | ||
| Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014. | Q36418201 | ||
| Multifacility Outbreak of Middle East Respiratory Syndrome in Taif, Saudi Arabia | Q36418205 | ||
| Association between Severity of MERS-CoV Infection and Incubation Period. | Q36617013 | ||
| The Characteristics of Middle Eastern Respiratory Syndrome Coronavirus Transmission Dynamics in South Korea | Q36645746 | ||
| Estimating the Severity and Subclinical Burden of Middle East Respiratory Syndrome Coronavirus Infection in the Kingdom of Saudi Arabia | Q36710116 | ||
| Spread of Mutant Middle East Respiratory Syndrome Coronavirus with Reduced Affinity to Human CD26 during the South Korean Outbreak | Q36736237 | ||
| Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients | Q36879745 | ||
| Outbreak of Middle East Respiratory Syndrome at Tertiary Care Hospital, Jeddah, Saudi Arabia, 2014 | Q36884958 | ||
| Clinical and Epidemiologic Characteristics of Spreaders of Middle East Respiratory Syndrome Coronavirus during the 2015 Outbreak in Korea. | Q37740446 | ||
| Descriptive epidemiology and characteristics of confirmed cases of Middle East respiratory syndrome coronavirus infection in the Makkah Region of Saudi Arabia, March to June 2014. | Q38593546 | ||
| Spatial modelling of contribution of individual level risk factors for mortality from Middle East respiratory syndrome coronavirus in the Arabian Peninsula | Q38651569 | ||
| Estimating and Modelling the Transmissibility of Middle East Respiratory Syndrome Corona Virus during the 2015 Outbreak in the Republic of Korea | Q38658221 | ||
| The epidemiology of Middle East respiratory syndrome coronavirus in the Kingdom of Saudi Arabia, 2012-2015. | Q38732808 | ||
| The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission | Q39149979 | ||
| Assessment of the Middle East respiratory syndrome coronavirus (MERS-CoV) epidemic in the Middle East and risk of international spread using a novel maximum likelihood analysis approach | Q39171246 | ||
| Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity. | Q39541934 | ||
| MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study | Q39611910 | ||
| Factors influencing preventive behavior against Middle East Respiratory Syndrome-Coronavirus among nursing students in South Korea. | Q39813282 | ||
| Impact of Comorbidity on Fatality Rate of Patients with Middle East Respiratory Syndrome. | Q40050351 | ||
| The predictors of 3- and 30-day mortality in 660 MERS-CoV patients. | Q40053331 | ||
| Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responses. | Q40094147 | ||
| Diagnostic delays in 537 symptomatic cases of Middle East respiratory syndrome coronavirus infection in Saudi Arabia | Q40125997 | ||
| MERS, SARS, and Ebola: The Role of Super-Spreaders in Infectious Disease | Q40135136 | ||
| Identified Transmission Dynamics of Middle East Respiratory Syndrome Coronavirus Infection During an Outbreak: Implications of an Overcrowded Emergency Department. | Q40175424 | ||
| Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia | Q40187493 | ||
| High fatality rates and associated factors in two hospital outbreaks of MERS in Daejeon, the Republic of Korea | Q40323196 | ||
| Outcome of strict implementation of infection prevention control measures during an outbreak of Middle East respiratory syndrome | Q40336178 | ||
| Risk factors for transmission of Middle East respiratory syndrome coronavirus infection during the 2015 outbreak in South Korea. | Q40414298 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systematic review | Q1504425 |
| infectivity | Q1662346 | ||
| P304 | page(s) | 574 | |
| P577 | publication date | 2018-05-02 | |
| P1433 | published in | BMC Public Health | Q15767009 |
| P1476 | title | MERS transmission and risk factors: a systematic review. | |
| P478 | volume | 18 |
| Q91808739 | A Comparative Analysis of Factors Influencing Two Outbreaks of Middle Eastern Respiratory Syndrome (MERS) in Saudi Arabia and South Korea |
| Q84316038 | Acute Respiratory Infection in Human Dipeptidyl Peptidase 4-Transgenic Mice Infected with Middle East Respiratory Syndrome Coronavirus |
| Q91642901 | An evidence-based framework for priority clinical research questions for COVID-19 |
| Q60953061 | CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice |
| Q90608248 | COVID-19 and smoking: A systematic review of the evidence |
| Q103019959 | COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature |
| Q101116329 | COVID-19 pandemic: an opportunity for tobacco use cessation |
| Q94487346 | COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives |
| Q92050462 | Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection |
| Q96647460 | Clinical Time Features and Chest Imaging of 85 Patients With COVID-19 in Zhuhai, China |
| Q102059016 | Clinical presentations, laboratory and radiological findings, and treatments for 11,028 COVID-19 patients: a systematic review and meta-analysis |
| Q94668254 | Complementary and alternative medicine use among outpatients during the 2015 MERS outbreak in South Korea: a cross-sectional study |
| Q92076061 | Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children |
| Q95617473 | Coronaviruses pathogenesis, comorbidities and multi-organ damage – A review |
| Q87461563 | Does SARS-CoV-2 has a longer incubation period than SARS and MERS? |
| Q98772279 | Estimation of incubation period distribution of COVID-19 using disease onset forward time: A novel cross-sectional and forward follow-up study |
| Q88976224 | Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study |
| Q94490959 | Factors Associated with Preventive Behaviours of COVID-19 among Hospital Staff in Iran in 2020: An Application of the Protection Motivation Theory |
| Q92290904 | Genetically Engineering a Susceptible Mouse Model for MERS-CoV-Induced Acute Respiratory Distress Syndrome |
| Q94592476 | Has there been an increased interest in smoking cessation during the first months of the COVID-19 pandemic? A Google Trends study |
| Q90005145 | Hospital-Acquired Pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) Guidelines. 2019 Update |
| Q91864071 | Household Transmission of SARS-CoV-2 |
| Q99711557 | Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections |
| Q91837405 | Is the ACE2 Overexpression a Risk Factor for COVID-19 Infection? |
| Q96111252 | Linking key intervention timings to rapid declining effective reproduction number to quantify lessons against COVID-19 |
| Q58595060 | MERS coronavirus outbreak: Implications for emerging viral infections |
| Q90127018 | Middle East respiratory syndrome |
| Q61443798 | Nonconventional opponents: a review of malaria and leishmaniasis among United States Armed Forces |
| Q84096797 | Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study |
| Q96302226 | Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement |
| Q96122408 | Oxygenation device with reservoir and PEEP (ODRPEEP) in patients with acute respiratory distress due to COVID-19 |
| Q99577432 | Protecting healthcare workers from SARS-CoV-2 and other infections |
| Q91725707 | Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review |
| Q94595160 | Rethinking high-risk groups in COVID-19 |
| Q100519036 | Review of novel human β-coronavirus (2019-nCoV or SARS-CoV-2) from the food industry perspective-Appropriate approaches to food production technology |
| Q98579825 | Separating the wheat from the chaff-COVID-19 in a German emergency department: a case-control study |
| Q91825701 | Severity of coronavirus respiratory tract infections in adults admitted to acute care in Toronto, Ontario |
| Q94561951 | Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic |
| Q97526846 | Systematic Review and Meta-Analysis of Sex-Specific COVID-19 Clinical Outcomes |
| Q89840059 | The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| Q63246564 | The double burden of diabetes and global infection in low and middle-income countries |
| Q90116852 | What can early Canadian experience screening for COVID-19 teach us about how to prepare for a pandemic? |
Search more.